Clinical Trials Logo

Carcinoma in Situ clinical trials

View clinical trials related to Carcinoma in Situ.

Filter by:

NCT ID: NCT03909282 Recruiting - Clinical trials for Ductal Breast Carcinoma in Situ

Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

NORDIS
Start date: March 22, 2019
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to compare by pathological findings surgical excision versus neoadjuvant radiotherapy followed by delayed surgical excision of ductal carcinoma in situ (DCIS)

NCT ID: NCT03870113 Not yet recruiting - Clinical trials for Cervical Intraepithelial Neoplasia

DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2

Start date: April 1, 2019
Phase: Phase 1
Study type: Interventional

To establish therapeutic dendritic cell (DC) vaccines targeting HPV 16/18 E6/E7 protein to block the progression of CIN1/CIN2 to cervical cancer and evaluate the safety and efficacy of the vaccines.

NCT ID: NCT03868475 Not yet recruiting - Breast Fibroadenoma Clinical Trials

Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions

VAPEX
Start date: January 2025
Phase: N/A
Study type: Interventional

This randomized controlled trial compares vacuum-assisted percutaneous excision to open standard surgical excision in women who have high-risk or borderline, non-malignant breast lesions with respect to efficacy, safety, cosmesis and patient satisfaction.

NCT ID: NCT03848039 Not yet recruiting - Clinical trials for Cervical Intraepithelial Neoplasia

Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9

HOPE9
Start date: December 2020
Phase: Phase 3
Study type: Interventional

This study evaluates the impact on disease relapse of presurgical 9-valent HPV vaccination versus placebo vaccination in women treated with LEEP (loop electrosurgical excision procedure) for CIN2+ (high grade cervical intraepithelial neoplasia) and initially invasive cervical cancer.

NCT ID: NCT03834532 Completed - Clinical trials for Breast Cancer Female

Living Well After Breast Surgery

Start date: February 18, 2019
Phase: N/A
Study type: Interventional

Decision making about whether to have breast reconstruction after mastectomy can be difficult, and previous studies have found that many women are not well informed about their options. Patient decision aids can improve decision quality for a variety of health conditions. This pilot randomized study seeks to determine how a patient decision aid about breast reconstruction affects the quality of decisions about reconstruction including patient knowledge, concordance between preferences and treatment, and decisional regret.

NCT ID: NCT03808818 Completed - Malignant Neoplasm Clinical Trials

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

Start date: August 1, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.

NCT ID: NCT03792516 Active, not recruiting - Vulvar Diseases Clinical Trials

Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)

ART-VIN
Start date: April 17, 2019
Phase: Phase 1
Study type: Interventional

This is a Phase I, proof-of-concept treatment study to evaluate the safety, tolerability and feasibility of topical artesunate ointment to treat high grade vulvar intraepithelial neoplasia (HSIL VIN2/3).

NCT ID: NCT03776487 Active, not recruiting - Clinical trials for Gastric Adenocarcinoma

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

Start date: January 7, 2019
Phase: Phase 2
Study type: Interventional

This pilot phase I/II trial studies the side effects and how well nivolumab and ipilimumab in combination with chemotherapy and radiation therapy work in treating patients with gastric cancer that can be removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as oxaliplatin and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Intensity-modulated radiation therapy uses thin beams of radiation of different strengths aimed at the tumor from many angles. This type of radiation therapy may reduce the damage to healthy tissue near the tumor. Giving nivolumab, ipilimumab, chemotherapy and radiation therapy may work better in treating patients with gastric cancer.

NCT ID: NCT03775213 Completed - Clinical trials for Ductal Carcinoma in Situ

Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)

Start date: October 12, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate a decision support tool for patients diagnosed with ductal carcinoma in situ (DCIS).

NCT ID: NCT03745846 Not yet recruiting - Clinical trials for Cervical Intraepithelial Neoplasia

A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization

Start date: December 2018
Phase: Phase 2
Study type: Interventional

To evaluate the efficacy and safety of composite gel containing black raspberry extract in removing HPV From patients With cervical intraepithelial neoplasia(CIN) after cervical conization